Serial #78502794
DEAD

Serial Number

78502794

Owner

PAION GmbH

Attorney

GARY D. KRUGMAN

Filing Date

Oct 20, 2004

Add to watchlist:

No watchlists yet
View on USPTO

Serial #78502794 Trademark

Serial Number: 78502794 • Registration: 3152858

Serial #78502794 is a trademark filed by PAION GmbH on October 20, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

PAION GmbH (4 trademarks)

Kaiserplatz 5
Stolberg 52222 , DE

Entity Type: 03

PAION DEUTSHLAND GMBH

MARTSTRASSE 10-12
AACHEN 52062 , DE

Entity Type: 03

Trademark Details

Filing Date

October 20, 2004

Registration Date

October 10, 2006

Published for Opposition

July 18, 2006

Cancellation Date

May 12, 2017

Goods & Services

[Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics]

Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment[ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents;] medical and clinical diagnostic reagents for clinical or medical laboratory use

[Computerized database management, namely, processing data for third parties]

Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use

[Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration]

[Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ]preparation of expert opinions in the field of[ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry], product research and development of medical devices and pharmaceutical preparations, [and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries;] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products[; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment;] scientific research on and development of[ medical diagnostic equipment and] pharmaceutical preparations and products for the treatment of[ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances,] nervous diseases, [diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases,] pain [and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 12, 2017 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 10, 2015 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 20, 2013 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 20, 2013 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 18, 2013 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 4, 2013 815F
TEAS SECTION 8 & 15 RECEIVED
Apr 4, 2013 E815
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2006 R.PR
PUBLISHED FOR OPPOSITION
Jul 18, 2006 PUBO
NOTICE OF PUBLICATION
Jun 28, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 25, 2006 PREV
ASSIGNED TO LIE
May 19, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
May 4, 2006 XAEC
EXAMINERS AMENDMENT E-MAILED
May 4, 2006 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 4, 2006 CNEA
AMENDMENT FROM APPLICANT ENTERED
Apr 20, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2006 CRFA
PAPER RECEIVED
Mar 23, 2006 MAIL
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 14, 2006 RCSC
LETTER OF SUSPENSION E-MAILED
Aug 10, 2005 GNSL
SUSPENSION LETTER WRITTEN
Aug 10, 2005 CNSL
AMENDMENT FROM APPLICANT ENTERED
Aug 4, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2005 CRFA
PAPER RECEIVED
Jul 27, 2005 MAIL
NON-FINAL ACTION E-MAILED
May 24, 2005 GNRT
NON-FINAL ACTION WRITTEN
May 24, 2005 CNRT
ASSIGNED TO EXAMINER
May 24, 2005 DOCK
NEW APPLICATION ENTERED
Oct 28, 2004 NWAP